What percentage of investments by provider ventures are actually getting adopted?
You would be surprised to learn that a few health systems are reporting that they have high rate of adoption of technologies they have invested.
Protenus rakes in $11M Series B led by Kaiser Permanente Ventures, F-Prime Capital Partners
Baltimore, Maryland-based startup Protenus has raised $11 million in a Series B round led by Kaiser Permanente Ventures and F-Prime Capital Partners. Arthur Ventures, LionBird Venture Capital and Cognosante Ventures also participated.
presented by
How to Optimize Your Phlebotomy Setup for Efficient Patient Care
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Care coordination business Collective Medical raises $47.5M Series A for expansion plans
"The funding allows us to deepen the clinical capabilities of the software without slowing our geographic expansion," said Collective Medical CEO Chris Klomp.
Kaiser Pemanente investment arm adds Hometeam to healthcare investments
The strategic investment could help Hometeam increase its geographic base beyond New York, New Jersey and Pennsylvania.
KP Ventures puts $10M into Vidyo, perhaps the first healthcare provider investment in unified communications
A Vidyo spokeswoman said that the company believes it to be the first strategic investment by a healthcare provider in a vendor of unified communications services.
Predictive Biosciences’ $25M Series C round to pay for clinical trials
Predictive Biosciences plans to use its now-completed $25 million Series C round to begin commercializing its biomarker-based bladder cancer test. Predictive Biosciences completed a $25 million Series C round, saying it plans to use the money to complete clinical trials for its CertNDx bladder cancer assay and ready it for market. The assay reduces the […]
presented by
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
Q&A: Hemosphere CEO Doris Engibous
After more than 20 years in corporate America, Doris Engibous says she was “big-companied out.” So the medical technology veteran jumped at the opportunity to move from California to Minnesota six years ago to become a first-time CEO for Hemosphere Inc., which has developed a vein-access device for chronic kidney disease patients who need hemodialysis. […]